Transmedic

Transmedic logo

Transmedic started in 1980 as an equipment distributor to cater to the medical needs of an increasingly affluent Asia. Today, it is a leading speciality partner of healthcare institutions and professionals.

Manufacturers trust us to promote and implement their latest technologies and remedies. Customers see us as a facilitator of medical advances.

Transmedic aspires to play a key role in bringing first world healthcare benefits to this region.

General contact:

CONTACT DETAILS OF DC BEAD DISTRIBUTORS IN SOUTHEAST ASIA

Singapore

Transmedic Pte Ltd
5 Jalan Kilang Barat
9th Floor Petro Centre
Singapore 159349
Tel: +65 6737 1945
Fax: +65 6737 3110
Email: enquiries@transmedic.com.sg
Web: www.transmedic.com.sg

Malaysia

Transmedic Healthcare Sdn Bhd
B4-1-1, Solaris Dutamas
No 1, Jalan Dutamas 1
50480 Kuala Lumpur
Malaysia

Tel: (603) 6205 3888
Email: enquiry@transmedic.com.my

Thailand

Transmedic (Thailand) Co., Ltd.
888/10 7th Floor
Mahatun Plaza Building
Ploenchit Road, Lumpini
Patumwan, Bangkok 10330
Thailand
Tel: +66 2 255 0405
Fax: +66 2 255 0409
Email: phatthaphon@transmedic.co.th

Indonesia

PT. Transmedic Indonesia
Perkantoran Menara ERA
Unit G-01
Jl. Senen Raya No. 135-137
Jakarta 10410, Indonesia
Tel: +62 21 380 1420
Fax: +62 21 380 1421
Email: josephine@transmedic-ind.com

Brunei

Cathay Scientific Instrument Co Sdn Bhd.
Unit 7, Ground Floor, Wisma 2000
Jalan Menglait, Simpang 51-22
Gadong BE3919, Brunei Darussalam
Tel: +673 (2) 449 225
Fax: +673 (2) 426 191
Email: cathay@brunet.bn

Philippines

AndroMed TRADE, Inc.
8728 Diamante St
Marcelo Green Village 5
Paranaque City, Metro Manila
Philippines 1700
Tel: +63 (2) 824 3675
Fax: +63 (2) 824 3675
Email: susana_gosalvez_pe@andromedtrade.com

Vietnam

15 Bis Luong Huu Khanh St.
Pham Ngu Lao Ward, Dist. 1
Ho Chi Minh City
Vietnam
Tel: +84 (8) 3925 0637
Fax: +84 (8) 3925 0639
Email: nguyenvanbang@tamhop.vn

Regulatory notices and product safety data

Worldwide (excluding USA)

Bead Block™ is CE marked and indicated for the treatment of a variety of hypervascular tumours (including Uterine Fibroids) and arteriovenous malformations (AVMs). For full prescribing information please refer to Bead Block instructions for use.

DC Bead® is CE marked and is indicated for the treatment of malignant hypervascular tumours and loading with doxorubicin drug. DC Bead® is also indicated for loading with irinotecan for the treatment of metastatic colorectal cancer (mCRC). Both indications may not be available in your territory. For full prescribing information please refer to DC Bead instructions for use.

DC BeadM1™ is indicated for loading with irinotecan for the treatment of metastatic colorectal cancer (mCRC). For full prescribing information please refer to DC Bead M1 instructions for use.

USA

In the USA, Bead Block™ is indicated for the treatment of hypervascular tumors and arteriovenous malformations (AVMs). For full prescribing information please refer to Bead Block USA Instructions for use.

LC Bead™ is cleared by the FDA for the embolization of hypervascular tumors and arteriovenous malformations (AVMs). For full prescribing information please refer to LC Bead instructions for use.

LC Bead M1™ is cleared by the FDA for the embolization of hypervascular tumors and arteriovenous malformations (AVMs). For full prescribing information please refer to LC Bead M1 instructions for use.

DC Bead is not currently available for sale or distribution in the USA. Both indications may not be available in your territory. 

DC Bead M1 is not currently available for sale or distributions in the USA. 

Canada

DC Bead® with doxorubicin is indicated for trans-arterial chemoembolization (TACE) of unresectable hepatocellular carcinoma (HCC). DC Bead are also intended to be loaded with irinotecan for the purpose of embolization of vessels supplying malignant colorectal cancer metastasised to the liver (mCRC), and delivery of a local, controlled, sustained dose of irinotecan to the mCRC. For full prescribing information please refer to DC Bead Canada Instructions for Use 

DC BeadM1 is primarily intended as an embolic agent to treat vessels supplying malignant colorectal cancer metastasised to the liver (mCRC). DC BeadM1 is also compatible with irinotecan, which can be loaded prior to embolisation and then, as a secondary action, elute a local, controlled and sustained dose to the mCRC after embolisation. For full prescribing information please refer to DC BeadM1 Canada Instructions for Use  

Tawain

DC Bead is approved by the Department of Health and is intended to be loaded with Mayne (Hospira) doxorubicin HCI for the purpose of embolisation of vessels supplying malignant hypervascularised tumour(s), and delivery of a local, controlled, sustained dose of doxorubicin.  DC Bead is also indicated for the embolisation of nidus vessels without medication.  Approved size ranges in Taiwan are 300-500µm and 500-700µm.

Hong Kong

PRECISION Bead™ is indicated for the delivery of Doxorubicin, a chemotherapeutic agent for the treatment of malignant hypervascular tumours, where Trans Arterial Embolisation (TAE) is not contraindicated.